Simpson Thacher is representing Hellman & Friedman in connection with its entering into definitive agreements to recapitalize Pharmaceutical Product Development, LLC Under the agreements, Hellman &…
Pharmaceutical Product Development’s $550 Million Recapitalization With Existing Owners and New Investors
